Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in OncologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper.Crit Rev Oncol Hematol. 2019; 134: 39-45
- Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer.Clin Cancer Res. 2017; 23: 6708-6720
- Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer.Nat Med. 2017; 23: 114-119
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017.Neuro Oncol. 2020; 22: iv1-iv96
- Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.JAMA. 2017; 318: 2306-2316
- Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.Lancet Oncol. 2008; 9: 453-461
- Metastatic colonization by circulating tumour cells.Nature. 2016; 529: 298-306
- Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer.Sci Transl Med. 2010; 2: 25ra23
- Circulating tumor cells, disease progression, and survival in metastatic breast cancer.N Engl J Med. 2004; 351: 781-791
- Circulating tumor cells in colorectal cancer: past, present, and future challenges.Curr Treat Options Oncol. 2010; 11: 1-13
- Circulating tumor cells in prostate cancer diagnosis and monitoring: an appraisal of clinical potential.Mol Diagn Ther. 2014; 18: 389-402
- Detection of brain tumor cells in the peripheral blood by a telomerase promoter-based assay.Cancer Res. 2014; 74: 2152-2159
- Isolation of Circulating Tumour Cells in Patients With Glioblastoma Using Spiral Microfluidic Technology - A Pilot Study.Front Oncol. 2021; 11: 681130
- Circulating tumor cell is a common property of brain glioma and promotes the monitoring system.Oncotarget. 2014; 7: 71330-71340
- Brain tumor cells in circulation are enriched for mesenchymal gene expression.Cancer Discov. 2014; 4: 1299-1309
- Capture and Detection of Circulating Glioma Cells Using the Recombinant VAR2CSA Malaria Protein.Cells. 2019; 8
- Identifying circulating glioma cells and their clusters as diagnostic markers by a novel detection platform.Clin Transl Med. 2021; 11: e318
- Role of circulating tumor cell detection in differentiating tumor recurrence from treatment necrosis of brain gliomas.Biosci Trends. 2021; 15: 107-117
- Hematogenous dissemination of glioblastoma multiforme.Sci Transl Med. 2014; 6: 247ra101
- Detection of circulating tumour cell clusters in human glioblastoma.Br J Cancer Aug. 2018; 119: 487-491
- Circulating tumor cell status monitors the treatment responses in breast cancer patients: a meta-analysis.Sci Rep. 2017; 7: 43464
- Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.J Clin Oncol. 2008; 26: 3213-3221
- Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer.Clin Cancer Res. 2008; 14: 6302-6309
- A retrospective, quantitative assessment of disease burden in patients with leptomeningeal metastases from non-small-cell lung cancer.Neuro Oncol. 2020; 22: 675-683
- Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer.J Neurooncol. 2020; 148: 599-606
- Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors.Neuro Oncol. 2017; 19: 1248-1254
- Rare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumors.Neurology. 2013; 80: 1598-1605
- Circulating mutant DNA to assess tumor dynamics.Nat Med. 2008; 14: 985-990
- Detection of circulating tumor DNA in early- and late-stage human malignancies.Sci Transl Med. 2014; 6: 224ra24
- Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease.EMBO Mol Med. 2015; 7: 1034-1047
- Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer.Sci Transl Med. 2015; 7: 302ra133
- Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies.Int J Cancer. 2021; 148: 1014-1026
- The prognostic value of KRAS mutated plasma DNA in advanced non-small cell lung cancer.Lung Cancer. 2013; 79: 312-317
- Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients.Nat Commun. 2016; 7: 11815
- Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types.Mol Oncol. 2015; 9: 783-790
- Analysis of cell-free circulating tumor DNA in 419 patients with glioblastoma and other primary brain tumors.CNS Oncol. 2019; 8: CNS34
- Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study.Clin Cancer Res. 2020; 26: 397-407
- Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord.Proc Natl Acad Sci U S A. 2015; 112: 9704-9709
- Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid.Nat. 2019; 565: 654-658
- TERT Promoter Mutation Detection in Cell-Free Tumor-Derived DNA in Patients with IDH Wild-Type Glioblastomas: A Pilot Prospective Study.Clin Cancer Res. 2018; 24: 5282-5291
- Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay.Oncotarget. 2016; 7: 9707-9717
- The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients.Clin Cancer Res. 2018; 24: 3528-3538
- Detection of EGFRvIII mutant DNA in the peripheral blood of brain tumor patients.J Neurooncol. 2013; 115: 27-35
- Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma.Nat Commun. 2015; 6: 8839
- Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid.Clin Cancer Res. 2018; 24: 2812-2819
- Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid.J Neurooncol. 2021; 152: 47-54
- Detection of cell-free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients.EMBO Mol Med. 2018; 10
- Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid.J Clin Oncol. 2016; 34: 2404-2415
Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype. ClinicalTrialsgov Identifier: NCT03718767. Available at: https://clinicaltrials.gov/ct2/show/NCT03718767. Accessed Aug 28, 2021.
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
